Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pramipexole on recovery from chronic post-stroke aphasia
2013-002396-17Phase 2Terminated
- Sponsor
- Birmingham Community Healthcare
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pramipexole in post-stroke aphasia (2 arms), sponsored by Birmingham Community Healthcare. Primary endpoint: Change in language function (Western Aphasia Battery). Started Aug 2013; status: terminated.
02
Drugs
pramipexole
03
Conditions
post-stroke aphasia
Beyond the preview
Go deeper on 2013-002396-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002396-17.